OBN is the membership organisation supporting and bringing together the UK's emerging life science companies, corporate partners and investors. Our 380+ member companies are located across the Golden Triangle and beyond, and benefit from our networking, partnering, purchasing, advising, and advocacy activities. OBN organises BioTrinity - Europe's Leading Investment and Biopartnering Conference attracting over 1000 delegates (April 23-25, 2018).

Organisation type
Lee Pratley

One Nucleus

One Nucleus is a membership organisation for international life science and healthcare companies. We are based in Cambridge and London UK, the heart of Europe’s largest life science and healthcare cluster.

Established in 1997, and formerly known as ERBI, One Nucleus is a not-for-profit, membership organisation and located in Cambridge and London – the centre of Europe’s leading life science and healthcare cluster. More than 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.

Organisation type
Tony Jones

OxStem Limited

OxStem is a drug discovery company, spun-out from the University of Oxford, with the unique vision of developing in-situ cell programming therapies to treat what are typically (but certainly not exclusively) age-related conditions, such as Dementia, Heart Failure, Macular Degeneration (the leading cause of blindness in the developed world), Diabetes and Oncology.

The idea is straightforward – to use the Stem Cell and Medicinal Chemistry expertise within Chemistry and its associated partners at Oxford to identify new classes of drugs that can re-program or stimulate existing endogenous cells – awakening previously defunct or dormant cellular processes.

Dr Carolyn Porter
Chief Business Officer 
Dr Georg Terstappen